Core Oncology aims to link research investigators and oncology phase 1 units with relevant biopharmaceutical companies running early phase cancer clinical trials.
By working closely with both parties and utilising our extensive experience, Core can streamline the new clinical trial feasibility questionnaire process and save investigators much time and effort.
Under a mutually-agreed CDA between Core and the site, data on key services / capabilities are captured and maintained to avoid repetitive reporting by the site. This allows the clinical trial questionnaire to be focussed on key medical and therapeutic topics saving time and making the feasibility less of a burden for all parties.
